CMS unveils preliminary Aduhelm coverage decision January 11, 2022 Auto Bot Payer Issues 0 CMS intends for Medicare to cover Aduhelm, Biogen’s Alzheimer’s disease treatment, for patients taking part in clinical trials, the agency announced Jan. 11.
